Home » Newsletters » BioWorld Science

BioWorld Science

March 14, 2011

View Archived Issues

Phase I/II trials assess safety and immunogenicity of HIV vaccine F4/AS01

ATX-101 potentiates activity of chemotherapy in preclinical studies by disrupting cell cycle control

Phase I data support safety and tolerability of YH-4808 in healthy subjects

Vifor reports new hepcidin antagonists for treatment of anemia

Ambit Biosciences presents new tyrosine-protein kinase inhibitors

German researchers present novel agents for HIV

PET tracer [18F]-MK-3328 shows favorable pharmacological profile and promise in Alzheimer's disease

Kyowa Hakko Kirin begins phase III pegfilgrastim study in Japan

Novel activators of the K(Ca)2.3 channel synthesized by RaQualia researchers

Jasco Pharma and North Carolina Central University form research program

AFFiRiS' AD-02 Alzheimer's disease vaccine shows potential in phase I trial

Galapagos' GLPG-0187 enters phase Ib trial in patients with solid tumors

Oxford Vaccine Group receives grant from Action Medical Research to develop meningitis vaccine

Herceptin obtains additional approval in Japan for gastric cancer overexpressing HER2

Astellas files for Japanese approval of bixalomer for hyperphosphatemia

Janssen Pharma launches Stelara in Japan for psoriasis

Almirall launches Sativex in Spain for treatment of spasticity in MS

CTI gains rights to Chroma Therapeutics' antitumor drug tosedostat in the Americas

Collaboration established for research into beta-cell regeneration in diabetes

Phase III DEFEND-1 trial in type 1 diabetes does not meet primary endpoint

BioInvent advances phase II trial of cardiovascular drug candidate BI-204

Clinical evaluation of NVP-BKM-120 for treatment of endometrial and colorectal cancer under way

Phase I/II trial to assess safety/effectiveness of TRC-105 plus sorafenib in HCC is now recruiting

Preclinical anticancer activity supports entry of OCID-4681-S-01 in phase I trial in solid tumors

MRK-560 shows preference for PS-1-containing gamma-secretases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...